Cited by 58Schizophrenia research and treatmentNeurotransmitter Receptor Influence on BehaviorNeural and Behavioral Psychology Studies

Striatal dopamine, reward, and decision making in schizophrenia

Open access
Deserno, Lorenz, Schlagenhauf, Florian, Heinz, Andreas·2016·Dialogues in Clinical Neuroscience

Abstract

Elevated striatal dopamine function is one of the best-established findings in schizophrenia. In this review, we discuss causes and consequences of this striata! dopamine alteration. We first summarize earlier findings regarding striatal reward processing and anticipation using functional neuroimaging. Secondly, we present a series of recent studies that are exemplary for a particular research approach: a combination of theory-driven reinforcement learning and decision-making tasks in combination with computational modeling and functional neuroimaging. We discuss why this approach represents a promising tool to understand underlying mechanisms of symptom dimensions by dissecting the contribution of multiple behavioral control systems working in parallel. We also discuss how it can advance our understanding of the neurobiological implementation of such functions. Thirdly, we review evidence regarding the topography of dopamine dysfunction within the striatum. Finally, we present conclusions and outline important aspects to be considered in future studies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.31887/dcns.2016.18.1/ldeserno

Cites

120 of 120 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Nucleus accumbens dysfunction has been heavily implicated in schizophrenia.

    “In ventral striatum, nucleus accumbens (NAc) dysfunction has been heavily implicated in schizophrenia [19, 20].”

    From Linking haploinsufficiency of the autism- and schizophrenia-associated gene Cyfip1 with striatal-limbic-cortical network dysfunction and cognitive inflexibility (2024) · cites this paper as [20]

    The Reward anticipation section reports replicated reductions in ventral striatal activation in unmedicated and medication-naive patients with schizophrenia, supporting the broader ventral-striatum claim. It does not specifically identify nucleus accumbens dysfunction in those patients, and it notes that the reduction was not observed in patients taking second-generation antipsychotics. Page numbers are unavailable in our copy. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [6]Howes OD. Kambeitz J. Kim E. et al The nature of dopamine dysfunction in schizophrenia and what this means for treatment. Arch Gen Psychiatry 2012 69 8 776 786 22474070 PMC3730746
  2. [87]Wang XJ. KrystaI JH. ComputationaI psychiatry. Neuron. 2014 84 3 638 654 25442941 PMC4255477

Cited by

Sorted by citations

Authors
Deserno, L., Schlagenhauf, F., & Heinz, A.
Affiliations
  • Max Planck Institute for Human Cognitive and Brain Sciences (DE)
  • Charité – Universitätsmedizin Berlin (DE)
Corresponding author
Deserno, Lorenz
Venue
Dialogues in Clinical Neuroscience
Published
2016-03-31
Volume
18
Issue
1
Pages
77-89
ISSN
  • 1294-8322 (ISSN-L)
  • 1958-5969
OpenAlex
W2340310467
Cited by
58
References
120
Citations by year
2026: 5 · 2025: 7 · 2024: 7 · 2023: 4 · 2022: 8 · 2021: 7 · 2020: 1 · 2019: 6 · 2018: 4 · 2017: 7 · 2016: 2
FWCI
5.63
Type
journal article
Language
en
Open access
Locations
  • Dialogues in Clinical Neuroscience (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Max Planck Digital Library (submittedVersion)
  • MPG.PuRe (Max Planck Society) (submittedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
Keywords
schizophrenia, striatal dopamine, reward processing, reward anticipation, decision-making, reinforcement learning, computational modeling, functional neuroimaging
MeSH terms
Animals, Corpus Striatum, Decision Making, Dopamine, Humans, Nerve Net, Reward, Schizophrenia, Functional Neuroimaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review